During the past decade, Blantyre CRS (Johns Hopkins Research Project/College of Medicine) conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blantyre CRS (Johns Hopkins Research Project/College of Medicine)" #1 collaborator was "Kamuzu University of Health Sciences" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator, "AIDS Malignancy Consortium" with 1 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Blantyre CRS (Johns Hopkins Research Project/College of Medicine)" are "HIV Infections" (4 trials), "HIV Exposed Uninfected" (1 trials), "HIV-1 Infection" (1 trials), "HUU Unexposed Uninfected" (1 trials) and "Pregnancy Related" (1 trials). Many other conditions were trialed in "Blantyre CRS (Johns Hopkins Research Project/College of Medicine)" in a lesser frequency.

Most popular intervention types in "Blantyre CRS (Johns Hopkins Research Project/College of Medicine)" are "Drug" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Truvada Tablet" (2 trials), "Bleomycin and Vincristine (BV)" (1 trials), "Butterfly iQ" (1 trials), "Co-formulated Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate (EFV/FTC/TDF)" (1 trials) and "Cognitive Games Training" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blantyre CRS (Johns Hopkins Research Project/College of Medicine)" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Blantyre CRS (Johns Hopkins Research Project/College of Medicine)". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Blantyre CRS (Johns Hopkins Research Project/College of Medicine), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blantyre CRS (Johns Hopkins Research Project/College of Medicine), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".